Focused Ultrasound for Targeted Drug Delivery in Huntington’s Disease
Author Information
Author(s): Helal Mohamed Mohsen, Ibrahim Arwa Amer, Beddor Ahmad, Kashbour Muataz
Primary Institution: Zagazig University
Hypothesis
Can focused ultrasound (FUS) effectively deliver therapeutic agents across the blood-brain barrier in Huntington's disease?
Conclusion
Focused ultrasound shows promise as a non-invasive method to enhance drug delivery for Huntington's disease treatment.
Supporting Evidence
- Focused ultrasound has been shown to safely open the blood-brain barrier in animal models.
- Preclinical studies indicate that FUS can enhance the delivery of neuroprotective agents in Huntington's disease models.
- FUS has demonstrated a favorable safety profile in clinical trials for other neurodegenerative diseases.
Takeaway
Focused ultrasound is like using a special sound to open a door in the brain that lets medicine in to help people with Huntington's disease.
Methodology
The review discusses preclinical studies and clinical trials involving focused ultrasound and its effects on drug delivery across the blood-brain barrier.
Limitations
The clinical application of FUS in Huntington's disease is still in its early stages, and no trials have been completed specifically for HD patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website